Analysis for GEHC

📈 Growth & Financial Trajectory

GE HealthCare demonstrates an 8-quarter trajectory of steady revenue, rising from about $4.86B in 2024 Q3 to about $5.30B in 2026 Q2, an approximate 8.9% expansion. Net income attributable to parent climbs from roughly $470M to $561M, a ~19% gain, though quarterly results exhibit dispersion (peaks near $721M in 2024 Q4). This reflects resilient demand with improving profitability alongside ongoing investment needs.

💰 Margins & Cash Flow

Across quarters, gross margins run in the low-to-mid 40% range, latest at about 41%, with operating margins in the mid-teens (roughly 14–16%). Operating cash flow has remained positive in each quarter, e.g., ~$168M in the latest period, while investing/financing outflows moderate overall cash flow. The pattern signals solid operating leverage but ongoing capital expenditure and financing needs.

🛡️ Balance Sheet & Liquidity

Total assets sit near $37B, with liabilities around $26B and equity near $11B in the latest quarter, indicating a solid balance sheet. Current assets against current liabilities yield a liquidity cushion around 1.0–1.3x. Long-term debt trails at roughly $10B, supporting a balanced leverage profile given substantial equity against liabilities.

⚠️ Key Drivers & Risks

• Drivers: steady hospital imaging/diagnostics demand; potential upside from AI-assisted imaging adoption.
• Risks: cyclical healthcare capex sensitivity; valuation risk tied to reimbursement/macro shifts.